Synthomer plc (LON:SYNT - Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 243.55 ($3.07) and traded as low as GBX 170 ($2.14). Synthomer shares last traded at GBX 174 ($2.19), with a volume of 241,692 shares trading hands.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on the stock. Berenberg Bank dropped their target price on shares of Synthomer from GBX 375 ($4.73) to GBX 340 ($4.28) and set a "buy" rating for the company in a report on Tuesday, August 13th. Canaccord Genuity Group lowered their target price on Synthomer from GBX 300 ($3.78) to GBX 275 ($3.47) and set a "buy" rating for the company in a report on Friday, October 4th.
View Our Latest Stock Analysis on SYNT
Synthomer Trading Up 1.6 %
The company has a debt-to-equity ratio of 77.42, a quick ratio of 0.97 and a current ratio of 1.90. The stock has a market capitalization of £284.61 million, a PE ratio of -285.25, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. The business's 50-day moving average is GBX 194.27 and its two-hundred day moving average is GBX 243.03.
About Synthomer
(
Get Free Report)
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
See Also
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
